Putin's bet against aging

The longevity race has had one recognizable face: Silicon Valley money. Bezos funds Altos Labs, Altman funds Retro Biosciences, Thiel has chased it for years. Russia has now planted a sovereign flag on the same ground. Its 'New Health Preservation Technologies' program, unveiled in 2024 and personally championed by Vladimir Putin, carries roughly 2 trillion rubles — about $26 billion — and a 2030 deadline to grow replacement organs by 3D-printing living tissue and breeding genetically compatible mini-pigs whose organs a human body won't reject.

It is run from inside Putin's circle: his daughter, an endocrinologist, oversees the genetics side, and the head of the Kurchatov Institute runs the science. State researchers say they have already printed human cartilage and a mouse thyroid gland, and a deputy science minister has called an anti-aging gene therapy 'one of the most promising avenues in the fight against aging.'

Here is the catch that makes this a story about power rather than biology: the program has published almost nothing in the major international journals where such claims get checked. A Russian bioprinting pioneer who left the country told the Journal the scientists are probably telling Putin what he wants to hear to keep the money flowing. What matters is not whether Russia cures aging — it likely won't by 2030 — but that a nation-state now treats indefinite lifespan as a matter of prestige worth $26 billion, the same way it once treated rockets and reactors.